Base Editing: Advancements and the Future of Gene Therapy
Keywords:Base Editing, Gene Therapy
The work done on CRISPR-Cas9 has pioneered the way for base editing, a technology that utilizes RNA-guided nucleases and other components of CRISPR systems along with a specific deaminase that can convert a C base to a T base, or a G to an A. Base editing focuses particularly on converting point mutations, which lead to the majority of human genetically linked diseases. After the conversion from a problematic gene, the DNA sequence is changed, effectively changing the genome’s identity. This research paper focuses on advantages and current applications of base editing using laboratory based and therapeutics based research, along with highlighting current drawbacks and future theoretical applications of the technology
References or Bibliography
[HL19] Kevin T. Zhao Shannon M. Miller Nicole M. Gaudelli Benjamin
L. Oakes Christof Fellmann David F. Savage Huang, Tony P. and
David R. Liu. Circularly permuted and pam-modified cas9 variants
broaden the targeting scope of base editors. Nature Biotechnology,
[KJ15] Michelle S. Prew Shengdar Q. Tsai Ved V. Topkar Nhu T. Nguyen
Zongli Zheng Andrew P.W. Gonzales Zhuyun Li Randall T. Peterson
Jing-Ruey Joanna Yeh Martin J. Aryee Kleinstiver, Benjamin P. and
J. Keith Joung. Engineered crispr-cas9 nucleases with altered pam
specificities. Nature, 2015.
[KL16] Yongjoo B. Kim Michael S. Packer John A. Zuris Komor, Alexis C.
and David R. Liu. Programmable editing of a target base in genomic
dna without double-stranded dna cleavage. Nature, 2016.
[LL17] Yajing Liu Yanting Zeng Jianan Li Lijie Wang Guang Yang Dunjin Chen Xiaoyun Shang Jia Chen Xingxu Huang Li, Guanglei and
Jianqiao Liu. Highly efficient and precise base editing in discarded
human tripronuclear embryos. Protein Cell, 2017.
[RL18] Holly A. Rees and David R. Liu. Base editing: precision chemistry
on the genome and transcriptome of living cells. Nature Reviews
[The19] Beam Therapeutics. Beam therapeutics presents data on multiplex
base editing for engineered car-t cells at american society of gene and
cell therapy 22nd annual meeting. 2019.
[WM19] Cara-lin Lonetree Mitchell G. Kluesner Matthew J. Johnson Emily
J. Pomeroy Miechaleen D. Diers Walker S. Lahr Garrett M. Draper
Nicholas J. Slipek Branden A. Smeester Klaus N. Lovendahl Amber
N. McElroy Wendy R. Gordon Mark J. Osborn Webber, Beau R.
and Branden S. Moriarity. Highly efficient multiplex human t cell
engineering without double-strand breaks using cas9 base editors.
Nature Communications, 2019.
[ZH18] Jianan Li-Guanglei Li Shisheng Huang Wenxia Yu Yu Zhang Dunjin
Chen Jia Chen Jianqiao Liu Zeng, Yanting and Xingxu Huang. Correction of the marfan syndrome pathogenic fbn1 mutation by base
editing in human cells and heterozygous embryos. Molecular Therapy, 2018
Copyright (c) 2022 Aditi Chatterjee
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The copyright holder for this article has granted JSR.org a license to display the article in perpetuity.